August 2021: Ozempic Could Be Linked to Increased Risk of Diabetic Retinopathy Study results examining diabetic retinopathy (DR) in patients taking semaglutide found a higher risk for DR complications in patients with proliferative and non-proliferative DR at baseline. However, researchers acknowledge that worsening DR could be due to rapid drops in blood glucose levels from diabetic medications
GLP-1 contributes to overall maintenance of glucose homeostasis through the reduction of glucagon secretion, while preclinical evidence suggests beneficial effects on pancreatic -cell proliferation, survival, and inhibition of apoptosis [34, 36, 37]
(PubMed) Clark WM, Wechsler LR, Sabounjian LA, Schwiderski UE, Citicoline Stroke Study Group
Contact your pharmacy if you have questions about their specific stability testing protocols
hosts regular webinars on GLP-1 therapy free to attend